Advertisement
Advertisement
Wuxi AppTec
TOPIC
 / company

Wuxi AppTec

Wuxi AppTec
Wuxi AppTec
Wuxi AppTec is Asia's largest provider of contract pharmaceutical research, helping drug makers shorten their discovery and development procedures. Its platform is used by more than 6,000 customers, including biotech and pharmaceutical companies, research institutions, researchers, scientists and entrepreneurs in more than 30 countries. The company was founded by Ge Li, who also chairs Wuxi Biologics.
Chairman / President
Li Ge
CEO / Managing Director
Chen Minzhang
CFO / Finance Director
Shi Ming
Industry
Biopharmaceutical
Website
wuxiapptec.com
Headquarters address
288 Fute Zhong Road Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, China
Stock Code
SEHK:603259
SSE:603259
Year founded
2000
LATEST China Science NEWS

UN climate body presses on after US quits, while China leads with renewables

videocam
11
Jim Skea, chair of the Intergovernmental Panel on Climate Change, says carbon dioxide removal is “the only way in which you can actually cool the planet again” if global temperatures surpass a key benchmark. Photo: Anadolu via Getty Images

China’s Tiangong space station to double in size as Nasa phases out ISS

videocam
16
The Tiangong space station will eventually comprised six modules. Photo: CMSA

Xi urges ‘disruptive innovation’ to boost China amid US tech race

videocam
Chinese President Xi Jinping speaks at a symposium on strengthening the country’s basic research, in Shanghai on Thursday. Photo: Xinhua

Oxford AI star Song Yuhang returns to China, but why did he leave chip start-up?

videocam
9
AI pioneer Song Yuhang has joined Nanjing University’s School of Artificial Intelligence. Photo: Handout

Are US agents around Trump armed with Chinese red dot sights?

videocam
9
Security officials react as a shooter opens fire at the White House Correspondents’ Association dinner, in Washington on April 25. Online commenters showed interest in the female agent’s drawn Glock pistol and what appeared to be a Holosun sight. Photo: Reuters
MORE China Science NEWS
WuXi AppTec’s R&D centre in Shanghai. Photo: CFOTO/Future Publishing via Getty Images
Hong Kong company reporting season

WuXi AppTec shares surge 14% in Hong Kong after record first-quarter earnings

The Chinese company’s revenue rose nearly 29 per cent to 12.44 billion yuan, while profit surged about 27 per cent to 4.65 billion yuan.

China’s private sector

WuXi AppTec posts record first-quarter revenue on strong global demand

China’s private sector

US reshoring drive casts shadow over China’s contract drug makers, analyst says

China’s private sector

Lab monkey price tag climbs to US$20,000 thanks to China’s biotech boom

The cost of a single monkey exceeds the average annual salary in China and approaches a pandemic-era spike amid growth in drug licensing deals.

Founder Securities expects the annual domestic supply of experimental monkeys in China to range between 49,000 and 52,400 animals from 2025 to 2027. Photo: Shutterstock
US-China relations

Pentagon adds Chinese firms to military list, then withdraws filing

Move weeks before Trump-Xi summit highlights mixed signals from Washington and injects fresh uncertainty into fragile US-China truce.

videocam
4
Hong Kong stock market

Hong Kong stocks climb as yuan strengthens and investors broaden focus beyond US

Hang Seng Index advances as investors shift focus, boosting Asian equities, with pharmaceutical and healthcare shares leading gainers.

Advertisement
Advertisement
Advertisement
United States

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.

US drugmakers are increasingly looking to Chinese biotechs as an answer to the revenue gaps left by the looming ‘patent cliff’. Illustration by Henry Wong
US-China relations

US lawmakers want DeepSeek, Xiaomi added to list of China military-linked firms

Republicans want to add 19 more entities to the document that already includes tech giant Tencent Holdings and major ‍battery maker CATL.

videocam
17
Science

Why US lawmakers killed a proposal targeting science efforts with China

US researchers and industry experts warn that even the revised version may have unintended consequences.

videocam
11
Hong Kong stock market

Hong Kong stocks end higher as China stimulus hopes spark property rally

Market sentiment buoyed by China homebuyer loan support talk and Vanke debt progress.

Hong Kong stocks rally in the afternoon. Photo: Shutterstock
Hong Kong stock market

Hong Kong stocks extend losses amid rate-cut caution, muted China policy outlook

Global banks cite lack of urgency in policy signals; Wall Street retreat adds pressure on sentiment.

Shares of Semiconductor Manufacturing International Corporation decline in early Tuesday trading in Hong Kong. Photo: Shutterstock
Hong Kong stock market

Hong Kong stocks fall as US data delay, Fed policy uncertainty hit sentiment

The US government will release nonfarm payrolls for September on Thursday, the first data since the 43-day shutdown.

Hong Kong stock market

Hong Kong stocks fall for a second day as AI bubble fears hit Wall Street

Losses mirror Wall Street after Palantir Technologies tumbled 8 per cent despite beating revenue estimates.

Hong Kong stock market

Hong Kong stocks rise as China-US trade progress boosts sentiment

Preliminary deal made in Kuala Lumpur raises hopes for stabilisation in the trade relationship between the world’s top two economies.

Chinese Vice Premier He Lifeng poses for a photo with US Treasury Secretary Scott Bessent in Kuala Lumpur, Malaysia, on October 25, 2025. Photo: Xinhua
Hong Kong stock market

Hong Kong stocks mirror Wall Street slide as gold and silver extend retreat

Traders weigh mixed signals from Donald Trump, who acknowledges potential meeting with Xi Jinping might not happen.

The Hang Seng Index tracked weakness on Wall Street, where a recent rally lost steam. Photo: Jelly Tse
Hong Kong stock market

Hong Kong stocks post longest decline in 9 months on renewed US-China tensions

Markets react to Trump’s threat to impose a 100 per cent tariff on all Chinese imports and restrict critical software exports from November.

Biomedicine: Geopolitics

Trump’s tariffs on imported drugs ‘not a big concern’ for China’s pharma firms

Chinese drug makers have ‘minimal sales exposure to the US’, Jefferies analysts say.

Advertisement
Advertisement
Advertisement
Hong Kong stock market

Hong Kong stocks cap weekly decline on valuation, tariff jitters

‘Gravity has reasserted itself’ and the global US$15 trillion rebound this year ‘now feels stretched’, investor says.

A view of Exchange Square in Central on April 7, 2025. Photo: Jelly Tse
Hong Kong stock market

Hong Kong stocks drop after Fed fails to signal aggressive rate road map

‘The challenge for investors is a Fed that is not yet willing to endorse their discounted future path of much lower interest rates,’ analyst says.

Hong Kong stock market

Hong Kong stocks waver as investors await rate-cut clarity

Ample domestic and external liquidity should fuel another rally in Hong Kong this month, strategists at China Merchants Securities say.

Biomedicine: Companies

Chinese biotech firm MGI’s DNA sequencers gaining in the market, BGI CEO says

MGI’s latest product, the DNBSEQ-T7+, can sequence 144 human genomes a day, or one every 10 minutes.

MGI Tech’s DNA sequencers offer the best “comprehensive value” in terms of time, quality and cost, according to BGI Group CEO Yin Ye. Photo: Shutterstock
Hong Kong stock market

Hong Kong stocks slip from 4-year high amid fears of US sanctions on drug makers

The Trump administration has been discussing severe restrictions on medicines from China, according to The New York Times.

Hong Kong stocks fell on Thursday. Photo: EPA
Banking & finance

China’s healthcare segment eyes record fundraising amid global investor surge

China biotech remains a market bright spot with strong growth, driven by out-licensing, efficiency improvements and cost control.

China technology

China’s biotech industry is gaining on the US. Can tariffs hold them back?

Pharmaceutical firms in China have grown fast, but geopolitics and a long head start could keep US-based leaders at industry apex - for now.

videocam
Hong Kong stock market

Mainland Chinese and Hong Kong stocks end the week on a high note

Shanghai Composite Index rises 1.5 per cent to 3,825.76, the highest since August 17, 2015.

videocam
The Hang Seng Index is displayed on a digital screen at the Hong Kong stock exchange. Photo: AP Photo
China economy

Editorial | As stimulus beds in, this Chinese stock rally may have legs

Encouraged by government stimulus, strong earnings and low deposit rates, investors are returning to Chinese stocks.

A screen shows stock exchange and economic data in Beijing on August 12 after the US and China extended their trade truce for another 90 days. Photo: EPA
Banking & finance

Wuxi AppTec joins funding rush as appetite grows for China’s biotech

WuxiAppTec raised HK$7.70 billion (US$981 million) in a sale of additional shares to fund its global expansion.

Hong Kong stock market

Hong Kong stocks slide to 2-week low on Fed decision, China manufacturing data

China’s official manufacturing purchasing managers’ index falls to 49.3 in July from 49.7 in June.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement